Overview

Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease

Status:
Unknown status
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The hypothesis is to evaluate if the treatment with Fexinidazole will lead to a better sustained clearance of the parasites at 6 months of follow-up when in comparison to placebo in patients with chronic indeterminate CD.
Phase:
Phase 2
Details
Lead Sponsor:
Drugs for Neglected Diseases